We are live on
!
Find out more
CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.67B
1-Year Est. Return
89%
This Fund
S&P 500
This Quarter
Est. Return
+22.56%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$295M
AUM Growth
+$46.7M
(+19%)
Cap. Flow
+$5.84M
Cap. Flow
% of AUM
1.98%
Top 10 Holdings %
Top 10 Hldgs %
32.39%
Holding
456
New
65
Increased
317
Reduced
38
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$6.09M |
| 2 |
PayPal
PYPL
|
+$4.84M |
| 3 |
STAAR Surgical
STAA
|
+$3.72M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$3.18M |
| 5 |
Microsoft
MSFT
|
+$2.94M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$7.85M |
| 2 |
iQIYI
IQ
|
+$7.2M |
| 3 |
ON Semiconductor
ON
|
+$4.1M |
| 4 |
Apple
AAPL
|
+$2.75M |
| 5 |
uniQure
QURE
|
+$2.39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 38.43% |
| 2 | Consumer Discretionary | 23.55% |
| 3 | Healthcare | 18.31% |
| 4 | Communication Services | 8.83% |
| 5 | Financials | 4.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Iovance Biotherapeutics
IOVA
$3.05B
| $18.6K | 0.01% |
3,038
+1,435
| +90% | +$9.9K |
|
|
DICE
227
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $18.5K | 0.01% |
646
+162
| +33% | +$4.8K |
|
228
Rocket Pharmaceuticals
RCKT
$374M
| $18.4K | 0.01% |
1,075
+306
| +40% | +$5.99K |
|
|
ACLX
229
DELISTED
Arcellx
ACLX
| $18.3K | 0.01% |
594
+149
| +33% | +$4.52K |
|
|
NUVL
230
DELISTED
Nuvalent
NUVL
| $18K | 0.01% |
691
+173
| +33% | +$5.12K |
|
231
Charles River Laboratories
CRL
$13.6B
| $18K | 0.01% |
89
| – | – |
|
232
Cadence Design Systems
CDNS
$89B
| $17.4K | 0.01% |
+83
| New | +$15.7K |
|
|
VRNA
233
DELISTED
Verona Pharma
VRNA
| $17.3K | 0.01% |
862
+245
| +40% | +$5.29K |
|
234
Agios Pharmaceuticals
AGIO
$2.04B
| $17.2K | 0.01% |
749
+191
| +34% | +$5.07K |
|
235
Adaptive Biotechnologies
ADPT
$4.02B
| $17.1K | 0.01% |
1,940
+487
| +34% | +$4.29K |
|
236
Monster Beverage
MNST
$90.1B
| $17.1K | 0.01% |
+632
| New | +$16.2K |
|
237
Ligand Pharmaceuticals
LGND
$5.85B
| $17K | 0.01% |
231
+60
| +35% | +$4.26K |
|
238
KLA
KLAC
$272B
| $16.8K | 0.01% |
+420
| New | +$16.6K |
|
239
IQVIA
IQV
$39.8B
| $16.7K | 0.01% |
84
| – | – |
|
240
Recursion Pharmaceuticals
RXRX
$1.76B
| $16.6K | 0.01% |
2,485
+639
| +35% | +$5.07K |
|
241
Summit Therapeutics
SMMT
$12B
| $16.5K | 0.01% |
9,453
+7,408
| +362% | +$20.2K |
|
242
Charter Communications
CHTR
$17.9B
| $16.4K | 0.01% |
+46
| New | +$17.2K |
|
243
O'Reilly Automotive
ORLY
$74.5B
| $16.1K | 0.01% |
+285
| New | +$15.6K |
|
244
Keros Therapeutics
KROS
$222M
| $15.9K | 0.01% |
373
+93
| +33% | +$4.7K |
|
|
DCPH
245
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $15.9K | 0.01% |
1,029
+342
| +50% | +$5.71K |
|
246
Marriott International
MAR
$92.5B
| $15.4K | 0.01% |
+93
| New | +$15.5K |
|
247
Protagonist Therapeutics
PTGX
$9.84B
| $15.3K | 0.01% |
667
+167
| +33% | +$2.81K |
|
248
Keurig Dr Pepper
KDP
$40.2B
| $15K | 0.01% |
+425
| New | +$14.9K |
|
249
JD.com
JD
$42.7B
| $14.9K | 0.01% |
339
+139
| +70% | +$7.18K |
|
|
RNAM
250
DELISTED
Avidity Biosciences
RNAM
| $14.7K | 0.01% |
959
+406
| +73% | +$8.93K |
|
Similar funds
HA
JPM
CPO
LCI
GWM
JIP
RMC
GACM
China Universal Asset Management Company's Q1 2023 Portfolio in Review
As of Q1 2023, China Universal Asset Management Company held 456 positions worth $295M, up 19% from $249M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
China Universal Asset Management Company's Q1 2023 filing shows 65 new, 317 increased, 38 reduced and 9 closed positions. Its largest new stake was Baidu: 20,500 shares worth $3.09M. The largest sale was Pinduoduo, an estimated $7.85M.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 35% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- China Universal Asset Management Company's largest Q1 2023 buy was Baidu: 20,500 shares worth $3.09M.
- China Universal Asset Management Company added most to NVIDIA in Q1 2023, an estimated $6.09M increase.
- China Universal Asset Management Company's biggest Q1 2023 reduction was Pinduoduo, cutting an estimated $7.85M.
- China Universal Asset Management Company fully exited Tower Semiconductor in Q1 2023, selling an estimated $1.94M.
- China Universal Asset Management Company's ten largest holdings make up 32% of its $295M portfolio in Q1 2023.
- China Universal Asset Management Company opened 65 new positions and closed 9 in Q1 2023.
- China Universal Asset Management Company's portfolio value rose 19% quarter-over-quarter to $295M.
Based on China Universal Asset Management Company's 13F filing for Q1 2023, filed 28 Apr 2023.